Obsessive-Compulsive Disorder in Dermatology

    Paraskevi Mavrogiorgou, A Bader, Eggert Stockfleth, Georg Juckel
    Image of study
    TLDR Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.
    The 2015 document highlights the intersection of dermatology and psychiatry in the treatment of OCD spectrum disorders, including trichotillomania, dermatillomania, and body dysmorphic disorder. It underscores the need for dermatologists to recognize these conditions, which often present with skin and hair symptoms, and to provide early treatment to prevent chronicity. The paper suggests a combination of psychotherapy and psychopharmacotherapy, particularly SSRIs and behavioral therapy, as effective treatments, with improvement seen in 50-70% of patients. Trichotillomania, characterized by compulsive hair pulling, has a lifetime prevalence of 0.6-4% and can be treated with serotonergic psychopharmaceuticals and minoxidil 2% to promote hair growth. The document calls for interdisciplinary cooperation for patient care and more extensive research due to the small number of cases in many studies. It also describes the psychopathology of OCD, including compulsive washing leading to skin conditions and the role of neurotransmitter imbalances, particularly serotonin.
    Discuss this study in the Community →

    Related Community Posts Join

    3 / 3 results

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Verteporfin day 119 update - donor hair regeneration human trial

      in Research/Science  146 upvotes 2 years ago
      A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.

    Related Research

    1 / 1 results